Does the speed of sternal retraction during coronary artery bypass graft surgery affect postoperative pain outcomes? A randomized controlled trial protocol

Author:

Petsikas Dimitri,Stewart CraigORCID,Phelan Rachel,Allard Rene,Cummings Michael,DuMerton Deborah,Parlow Joel,Payne Darrin,Tanzola Robert,Wang Louie,Saha TaritORCID

Abstract

Background: Chronic pain is a serious health issue impacting both the quality of life and productivity of patients. Chronic post-sternotomy pain (CPSP) is characterized by numbness, severe tenderness on palpation, allodynia, as well as constant pain across the anterior chest wall that can persist for months to years after sternotomy. All patients experience early post-operative pain following coronary artery bypass graft (CABG); unfortunately, approximately 30-40% of CABG patients subsequently develop CPSP.  Methods: The current study is a prospective, double-blinded, randomized controlled trial. A sample size of 316 randomly assigned patients (n=158 per group) will provide an 80% power at a 2-sided α of 0.05 to detect a 40% decrease in CPSP incidence at 6 months. Eligible patients scheduled for elective, primary coronary artery bypass graft surgery will be randomly assigned to the CONTROL group, in which sternal retraction is conducted over 30 seconds (as per standard practice); or the SLOW group, in which sternal retraction is achieved over 15 minutes. Surgical and perioperative anesthesia protocols between the two groups are otherwise the same. Our primary outcome is the incidence of CPSP at 6 months. Secondary outcomes are: CPSP incidence at 3 and 12 months, daily sternal incision pain intensity (numeric rating scale (NRS)) at rest and while coughing, and daily analgesic consumption while in hospital and at 7 days postoperatively; pain quality, quality of life, and pain interference with daily function at 3, 6, and 12 months post-operatively. Discussion: Our randomized controlled trial will determine whether retracting the sternum more slowly for exposure of the heart during CABG surgery will decrease the incidence and/or severity of CPSP. ClinicalTrials.gov registration: NCT02697812 (03/03/2016

Funder

Southeastern Ontario Academic Medical Organization (SEAMO) Academic Health Science Centre Alternative Funding Plan (AHSC AFP) Innovation Fund

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3